Ellsworth Advisors, LLC Amgen Inc Transaction History

Ellsworth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $2.5 Million - $2.87 Million	-12,590 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $492,041 - $576,486	2,318 Added 22.57%	12,590 $2.68 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $333,785 - $370,311	1,429 Added 16.16%	10,272 $2.5 Million
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $181,744 - $211,793	819 Added 10.21%	8,843 $2.2 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $1.74 Million - $2.07 Million	8,024 New	8,024 $1.85 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.